| Ytd | -78.12% | |
| 1y | -75.30% |
| Open | 1.51 | Prev Close | 1.54 | Low | 1.34 | High | 1.61 | Mkt Cap | 2.34M |
| Vol | 161.87K | Avg Vol | 1.30M | EPS | -47.64 | P/E | N/A | Forward P/E | -1.69 |
| Beta | 0.38 | Short Ratio | 0.43 | Inst. Own | 9.33% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 1.56 | 200-d Avg | 3.92 | 1yr Est | 33.00 |
Gainers InnovAge Holding (NASDAQ:INNV) shares increased by 10.8% to $11.65 during Tuesday's aft
Gainers bioAffinity Technologies (NASDAQ:BIAF) stock moved upwards by 54.3% to $10.17 during Wednes
U.S. stocks rose mid-session, led by materials; factory orders beat estimates. Linkhome, Purple Biot
U.S. stocks edged higher, led by the Dow and materials. Ollie’s beat EPS estimates; biotech and AI s
Purple Biotech (PPBT) stock surged premarket after receiving a USPTO patent allowance for its CAPTN-
Gainers Can Fite Biopharma (AMEX:CANF) shares moved upwards by 20.4% to $3.96 during Wednesday'
Purple Biotech Ltd. ("Purple Biotech" or the "Company") (NASDAQ/TASE: PPBT), a clini